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Abstract
Purpose – The economic shock posed by the current COVID-19 outbreak brought out a worldwide public health emergency with a close relationship
between the industrial marketing practices, the health level of society and its economic development. The purpose of this study is to analyse the
industrial dynamics in health care and their impact on economic growth and health status.
Design/methodology/approach – To empirically investigate the relationship between growth and health, the authors use a data set drawn from 29
selected Organisation for Economic Co-operation and Development (OECD) countries over the period 2000 and 2019. Using panel regressions, the authors
investigate the impact of the health-care industry measured in terms of health status, health expenditure, sales on pharmaceutical products, the number of
persons working in health care and the coverage by private health insurances. Fixed effect and random effect regressions are used to estimate this model.
Findings – Overall, the results are suggestive of a nexus between the industrial marketing dynamics of health-care context and economic growth –
both interacting and improving each other. As the quality of the health-care market enhances, the economy grows richer and the health status of
the population improves considerably.
Practical implications – To support health-care markets in OECD countries, health policymakers need to formulate a long-term industrial health
policy that addresses all the social and individual determinants of health.
Originality/value – To the best of the knowledge, this is the first study to provide a better understanding of the relationship between health-care
industrial dynamics and economic growth in OECD countries along different dimensions.
Keywords Industrial markets, Industrial marketing strategies, Health-care industry, Economic growth, OECD countries
Paper type Research paper
1. Introduction
The industrial dynamics in health-care context has received
increasing attention as a determinant of economic growth, both
in developed and developing countries (Bloom et al., 2004,
2019; Piabuo and Tieguhong, 2017; Well, 2007). Increasing
health care expenditures for industrial performance prolongs
life expectancy and increases general safety and welfare (Bedir,
2016). A strong consensus has emerged in the past decade that
the health-care organisations have to redesign their industrial
marketing strategies to search for a competitive advantage in
this complex context (Hwang and Christensen, 2008;
Schiavone and Simoni, 2019; Crick and Crick, 2020).
Recent scholars have recognised that health-care industrial
performance and economic growth are connected (Lee et al.,
2011; Jamaludin et al., 2013). Refining the management of
resources through strategicmarketing approaches in the health-
care industry is essential for economic growth and political
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stability (Wright and Taylor, 2005; Anderson et al., 2019;
Yildirim andCalıskan, 2020; Crick andCrick, 2020).
The economic shock posed by the current COVID-19
outbreak, which continues to spread internationally causing a
worldwide public health emergency is a demonstration of the
close relationship between the health-care industrial performance,
the health level of society and its economic development. As the
dire consequences caused by the COVID-19 pandemic become
more and more evident, issues of population health become even
more relevant than they were before. Improving the health status
of a population means to improve the physical and mental health
outcomes and well-being of people by making health care services
more widely available to all, whilst reducing health inequalities. It
requires action to deliver appropriate health and care services and
reduce the occurrence of ill health.
Sustained health expenditure, for example, improves the
health status of workers by causing increased labour efficiency
and productivity and, consequently, higher economic growth
(Schultz, 2005). Generally, healthier people can work harder
and longer. At the same time, given the existence of bidirectional
causality running between health expenditure and income (Erdil
and Yetkiner, 2004), increases in health expenditures for
industrial performance make possible higher labour supply and
productivity, which lead to a higher income. The effects of the
industry on the economy are significant not only because
industrial dynamics affect people’s health and their productivity
but also because today health represents one of the largest
economic industries in all middle and high-income countries.
In this study, we explore the industrial dynamics in health-care
context and their impact on economic growth and health status
in 29 selected Organisation for Economic Co-operation and
Development (OECD) countries. We assume that quality health
industrial practices contribute to improving the health and well-
being of the population, which are of vital interest to everyone,
their families and communities and are essential for the economic
and social development of countries. The entire health-care
ecosystem and its importance continue to grow and, with it, the
relevance of its contribution to the achievement of broader
objectives about managing the access, value and sustainability of
care. Indeed, health-care ecosystem is formed by the organised set
of people, institutions and resources that hold public
responsibility for the industry practices in providing health-care to
all citizens without distinction of gender, age, income and work
(Frow et al., 2016). In addition, a market access approach for
establishing supply conditions that reduce the time to market for
drugs or medical devices in health care has been the object of
study from different industrial perspectives (Schiavone and
Simoni, 2019; Huang et al., 2020). For these reasons, we advance
our study as an important innovation and research engine for
industrial marketing literature and a stimulus for competition
between professionals, innovative practices and products.
This background forms the basis of our motivation to explore
the topic of this paper with the following research question:
RQ1. How does the effectiveness and efficiency of the health-
care industrial dynamics contribute to improving
health status and economic growth?
To empirically investigate the relationship between growth and
health, we use a data set drawn from 29 selected OECD
countries over the period 2000 and 2019. As discussed in detail
below, our work finds that as the health-care industrial
performance advances the economy grows richer and health
status improves considerably. In line with previous studies
(Gupta and Mitra, 2004), the interdependence of economic
growth and health is empirically verified. Indeed, better
performance of the economy produces more resources to spend
on health-care industrial marketing practices and better health
status improves productivity, and therefore, economic growth.
Results also show that per capita health industrial expenditure
improves health status and also appears to raise growth. In
addition, more performing sales channels in the commercial
sector of the pharmaceutical market, as well as an increase in
the health-care workforce and in private health insurance (PHI)
coverage led to higher health status and economic growth.
Industrialisation, infrastructure and urbanisation have positive
impacts on economic growth. The health status is seen to vary
positively with urbanisation and infrastructure and inversely with
industrialisation. Whilst there is a growing body of research
analysing the relationship between health and economic growth
(Piabuo andTieguhong, 2017; Bloom et al., 2019), to the best of
our knowledge, this is the first study to provide a better
understanding of the relationship between health-care industrial
dynamics and economic growth in OECD countries along
different dimensions, namely, health status, health expenditure,
sales on pharmaceutical products, the number of persons
working in health care and the coverage by PHIs.
Finally, with the exploratory study, we contribute to existent
management studies by providing implications for practitioners,
scholars and institutions who intend to take advantage of the
opportunities offered by the health-care industry. The remainder
of this article is structured as follows. Section 2 reviews the main
theoretical contributions. Section 3 provides data and
econometric approach used in the study. Empirical findings are
discussed in Section 4. The main conclusions and implications
are stated in Sections 5–7.
2. Theoretical background
2.1 The dynamics of industrial marketing in health care
Health care is an ever-changing industry where companies are
constantly faced with the marketing challenges and opportunities
arising from a rapidly changing operating environment and ever-
growing demand for services (Lancioni, 2005; Omachonu and
Einspruch, 2010). During the current COVID-19 outbreak,
some collaborative business-to-business marketing strategies are
arising which include retailers sharing information about stock
levels or pharmaceutical companies working together to develop
a vaccine (Crick and Crick, 2020; Kang et al., 2020). Indeed,
industrial marketing in health care contributes to increased
productivity, to make the workforce more efficient, to healthier
aging and to a reduction in sickness costs (Pilon and Hadjielias,
2017; Schiavone and Simoni, 2019). Good health industrial
practices can support economic recovery and development
(Bhargava et al., 2001; Bloom et al., 2004, 2019). Thus, efficient
health-care industry systems – characterised by higher shares of
health expenditures in the gross domestic product (GDP) and a
large share of employment in the health sector – improve the
health status of the population (Popescu et al., 2018).
Industrial marketing relations has notable power in public
health-care contexts, based on its support of relationships
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amongst providers and customers and between providers and
their suppliers (Wright and Taylor, 2005). Indeed, relationship
marketing has been increased widely in the elevated value and
risk industrial markets. On the other hand, as Anderson et al.
(2019) attested, patients showed the necessity to take part in
health-care delivery, impacting caregivers’ roles. In this vein,
the value co-creation in industrial marketing strategies within
health-care contexts is conditioned on the relations amongst
different actors having different positions (e.g. patients’ families
and health-care organisations).
Increasing expectations on the quality of health-care delivery
have led to an increase in competitiveness in this sector, which
continues to grow (Hwang and Christensen, 2008). The
national health care spending in the US reached $3.81tn in 2019
($11,072 per capita) and accounted for 17.9% ofGDP. Looking
ahead, health spending is projected to reach $6.19tn by 2028,
accounting for nearly one-fifth of GDP (OECD, 2020). Health-
care innovation – defined by Thakur et al. (2012) as the adoption
of practices that help health-care practitioners work smarter,
faster, better and more cost-effectively, ensuring safety and
better outcomes for patients – has enabled a variety of
organisations (such as hospitals and pharmaceutical companies)
to innovatively create greater value for patients and all the
stakeholders involved in the health-care industrial processes
(Burns, 2012; Frow et al., 2016). The adoption of digital
technologies has deeply changed the way health-care industrial
processes and dynamics are managed, promoting cooperation
amongst several health-care players such as manufacturers,
distributors andmedical service providers (Laurenza et al., 2018;
Schiavone et al., 2020). Furthermore, third-party actors think
about innovative practices of doing business in the health-care
ecosystem for supporting the complex set of interconnections
between different health-care actors (Spena andCristina, 2019).
Digital transformation of the industrial practices in health care
through broad and deep use of health information technology
(HIT) has made services and processes more efficient, enabling
national health systems and doctors to provide better quality and
reduce drugs and medical devices costs and response times, with
many benefits for patients and for users of health industrial
practices in general (Agarwal et al., 2010). According to Thakur
et al. (2012), HIT systems increase health-care efficiency and
enable health-care organisations and individuals to achieve highly
reliable performance in a dynamic and unpredictable
environment. Advancement in health-care information
technology facilitates the way doctors communicate with patients
(Schiavone et al., 2020); it enables health-care practitioners to
collect a wide range of patient demographic, clinical data and the
development of integrated, accessible electronic health records
(Miller et al., 2016; Wang et al., 2018a, 2018b). Furthermore,
HIT enables health organisations and systems to offer their
diagnostic and treatment products/services in a simpler and faster
way (for example, via mobile Health apps and sensors, e-health
and wearable devices) (Agarwal et al., 2010; Laurenza et al.,
2018). Finally, it also favours the awareness of health-care
amongst consumers through online forums and other health-care
information systems (Thakur et al., 2012). In other words,
health-care innovation and technology are improving (and
prolonging) people’s life by contributing to bending the cost
curve in health care (Menon and Lee, 2000) and to enhancing
health-care quality, efficiency and industrial performance in
supply chain management (Chaudhry et al., 2006; De Vries and
Huijsman, 2011;Devaraj et al., 2013).
The enormous changes brought by disruptive technologies in
the health-care environment have made it necessary to develop
new innovative business models (Hwang and Christensen,
2008), with the shift from volume-oriented strategies to value-
oriented strategies (Chen et al., 2016) and from outcome-based
approaches to system-based approaches (Buttigieg et al.,
2016). Although health care has advanced tremendously over
the past two decades, the COVID-19 pandemic has highlighted
that there is still a long way to go to improve health-care
systems across the world. The COVID-19 pandemic is
changing the future of the health care industry by reshaping
health systems and restructuring health-care organisations,
which are accelerating their digital transformation roadmaps
and are preparing themselves to launch new initiatives when the
crisis passes (Crick andCrick, 2020).
2.2 Health-care industry and economic growth nexus in
OECD countries
Nowadays, industrial marketing in health care has an important
economic impetus as an employer (the health-care workforce
has increased over the years despite the general decline in
employment due to the economic crisis), as well as in the
construction and service sectors, indeed, federal governments
have invested significantly in building infrastructure able to
manage business negotiations between health actors through
industrial approaches for supply-chain management, market
access and drugs delivery (Hwang and Christensen, 2008;
Pilon and Hadjielias, 2017). For instance, recent scholars
established the important role of market access strategies to
have the marketing authorisation and better supply conditions
for pharmaceutical products (e.g. drugs or medical devices) to
enter in a new market (Smith, 2012; Toumi, 2017; Koçkaya
and Wertheimer, 2018; Schiavone and Simoni, 2019). On the
other hand, hospitals and specialised medical centres and are
now equipped with state-of-technology medical equipment
(Wright et al., 2019).
The impact of health on economic growth has attracted
considerable attention from social scientists and economists
over the years. A series of research studies have indicated the
close links between economic status and a whole host of well-
being indicators including health status and industrialisation
(Gupta and Mitra, 2004; Bloom et al., 2004; Casasnovas,
2007; Ogasawara, 2018). In this vein, Yildirim and Calıskan
(2020) explored the sustainable perspective to examine the
influence of health on economic growth. This study proved that
higher life expectations can impact economic growth positively
in countries with worse or low health status. Another recent
study demonstrated that health human capital significantly
impacts long-run economic growth (Sarpong et al., 2020).
Most of these studies consider health practices to be a crucial
aspect of human capital, and therefore, a critical ingredient of
economic growth. Bloom et al. (2004) reveal that good health
industrial practices has a positive, sizable and statistically
significant effect on economic growth. The authors find that a
one-year improvement in a population’s life expectancy
contributes to a 4% increase in output. Similarly, Well (2007)
has shown the positive impact of the health industry on GDP
per capita, stressing how eliminating health differences between
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rich and poor countries would reduce the variance of
logarithmic GDP per worker by 9.9% and reduce. Using life
expectancy as a broad measure of population health, Bhargava
et al. (2001) measure its impact on economic growth rates for
low-income countries committed in performing efficient and
effective health industrial practices. Results showed significant
effects of population health on economic growth. For the
poorest countries, a 1% change in life expectancy was associated
with an approximate 0.05% increase in growth rate.
Different scholars have confirmed that an increase in public
health expenditure has the power of improving health industrial
outcomes and economic growth in developing countries
(Olisakwe, 2019). In a recent study, Olisakwe (2019) analyses
the empirical evidence of a unidirectional causality that linkages
amongst public health expenditure, infant mortality rate and
economic growth inNigeria. Other studies focussing onOECD
countries show similar results. Joumard et al. (2010), for
example, evaluate the performance of the health industry in
OECD countries to discover its strengths and weaknesses and
propose the adoption of best policy practices to increase the
efficiency of health spending. Berger and Messer (2002) use
data from 20 OECD countries to explore the effects of factors
such as the public financing of health expenditures and
insurance coverage on health outcomes. The authors reveal
that health outcomes depend on the mix of health-care
expenditures and the type of health insurance coverage for
industrial practices; reduced mortality rates are associated with
increases in inpatient and ambulatory insurance coverage
whilst an increase in mortality rates is associated with increases
in the publicly financed share of health expenditures.
Using data from 17 OECD countries, Kim and Lane
(2013) find similar results. Specifically, the authors find
that government health expenditure in industrial practices
negatively affects infant mortality and positively affects life
expectancy at birth. Wang (2015) confirms that an increase
in health expenditure leads to better economic performance
in OECD countries. In the same vein, Weil (2014)
examines the relationship between the health industry and
economic growth, confirming that income per capita is
highly correlated with people’s health. As already
demonstrated in past studies, the author attributes the
relationship between health and income to the fact that
healthier individuals live longer and are more productive.
Using 2004–2013 annual data from 22 countries, Wang
et al. (2018a, 2018b) empirically examine the effects of
perceived health status (i.e. “health shocks”) on economic
growth, health expenditure and life insurance consumption.
The authors find that at low-income levels perceived health
status can make economic growth stagnant and reduce
health expenditures.
3. Hypotheses development
The health system, as an industry, is a key component of the
economy and one of the principal sources of employment in
most countries. Apart from creating jobs, the industrial
dynamics in health-care context, by its very nature,
contributes to the economy by influencing the competitiveness
and innovative marketing strategies in the global
pharmaceutical industry and consequently, the discovery of
new pharmaceutical and medical devices. Sorely tried by the
events that have come to define the recent history, health-care
organisations and pharmaceutical industries have shown their
ability to promptly address the large and urgent demand for
vaccines and treatment therapies for patients suffering from the
COVID-19. The health industry also affects the economy
through cross-border health care and remote provision of
services, its influence on the mobility of patients, professionals
and services and its association with the educational sector in
the form of clinical training and life sciences (Ried and Rau,
2017). Earlier research has shown that the health industry
affects countries’ economic growth whilst increasing the well-
being of individuals (Piabuo and Tieguhong, 2017). This is
even more true when it comes to developing countries, where
the development of a country’s health system is closely related
to the economic and social development of the country itself
(Olisakwe, 2019).
In the context of emerging economies, a recent African study
found a positive association between health expenditures and
economic growth (Somé et al., 2019). To the best of our
knowledge, no earlier study linked the industrial dynamics in
health-care context – intended as the set of factors that
constitute them and determine their development, producing
certain effects – to countries’ economic growth.
Therefore, the debate on how the health-care industrial
dynamics affect economic growth is unresolved. Hence, we
hypothesize the following:
H1. There is a positive association between the effectiveness
and efficiency of the health-care industry and the
economic growth of the countries analysed.
Health systems also affect the economy indirectly, helping to
improve individuals’ health status. Several studies have shown
that individuals in better health enjoy improved opportunities
for economic participation and contribution through a greater
presence in the labour market. Healthier individuals, therefore,
may also enjoy greater earning opportunities compared to their
less healthy counterparts. A study from Dwomoh et al. (2013),
for example, reveals that health and safety policies put in place
by Ghana’s timber companies have a positive impact on
employees’ performance by reducing the number of accidents
and injuries and helping them achieve their targets.
Another important benefit of the industrial dynamics in
health-care context is afforded by the PHI, which provides
primary financial protection for workers and their families
(Sekhri and Savedoff, 2005). PHI schemes can be valuable
tools to complement public health-financing options targeted
to programmes covering poor and vulnerable populations.
Finally, the industrial practices in health-care context make
an important contribution to societal well-being by delivering
high-quality health services and at an affordable cost. Quality
health services not only reduce mortality and prevent human
suffering, but they also improve the quality of life and ensure
healthier societies.
In light of the above, we hypothesize the following:
H2. There is a positive association between the effectiveness
and efficiency of the health-care industry and the overall
health status of the population.
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4. Data and methodology
In this section, we provide data on growth (GDP), foreign
direct investment (FDI), population growth, urban population,
health status, expenditures on health, industrial and
infrastructure, in 29 selected OECD countries [1]. The
countries’ selection was made considering the availability of
data relating to the variables of interest. Using panel
regressions, we investigate the impact of the health-care
industry measured in terms of health status, health
expenditure, sales on pharmaceutical products, number of
persons working in the health care and social work and the
coverage by PHI on the economic growth and status of the
health of the analysed countries.
We use as a dependent variable the economic growth,
measured by the annual percentage growth rate of the GDP
(GDPG) and health status (HS) with considering the crude birth
rate, crude death rate and life expectancy. We look at economic
growth and health status (HS) in a simultaneous framework,
suggesting that they influence each other following the two-way
causation thesis (Gupta and Mitra, 2004). This thesis suggests
that better health outcomes help boost economic growth by
increasing employment opportunities and the ability to earn,
respectively. According to Stark (1999), the growth performance
of the economy should improve with an increase in the health of
the population, which raises earnings, and therefore, consumer
spending. On the other hand, greater economic growth
generates a greater volume of resources to be spent on activities
related to development andwell-being, including health.
As independent variables, we use the FDI, Population growth
(POPG), health status (HS), Expenditures on health per capita
(HEXPC), percentage of population residing in urban areas
(URBAN), Percentage of the GDP originated from
manufacturing (IDUS), Percentage of the GDP originated
from manufacturing (IDUS), Percentage of the GDP originated
from transport service (INFRA), Sales of pharmaceutical
products on the domestic market (PHMR), Number of persons
(headcount) working in health care and social work (HEMP)
andThe percentages of population covered by PHI (PHICOV).
Data on used variables were collected from the World Bank
database and OECD database. The data sequence comprises
annual data from 2000 to 2019. Data sources and variables are
presented in Table 1.
Table 2 provides descriptive statistics related to the variables
used in this research. In particular, the average health
expenditure in studies countries is almost $2,779m.
Furthermore, health expenditure on average has a portion of
GDP, which is equal to 8.3%. The population growth in
OECD selected countries in 20 years is 0.5%.
With Gupta and Mitra (2004) research in mind and to
analyse and determine the relationship between health status
and economic growth in selected OECD countries, we applied
the followingmodels:
GDPGit ¼ a1 b 1FDIit 1 b 2POPGit 1 b 3IMRit
1 b 4URBANit 1 b 5INDUSTit 1 b 6INFRAit
1 b 7HEXPit 1 b 8PHMRit 1 b 9HEMPit
1 b 9PHICOVit 1 t t 1 « it
IMRit ¼ a1 b 1GDPit 1 b 2POPGit 1 b 3URBANit
1 b 4INDUSTit 1 b 5INFRAit 1 b 6HEXPit
1 b 7PHMRit 1 b 8HEMPit 1 b 9PHICOVit
1 t t 1 « it
where: GDP represents the gross domestic product in the
period t, FDI represents the foreign direct investment, POPG
represents the population growth, HS represents the health
status, URBAN represents the percentage of the population
residing in urban areas, INDUS represents the percentage of
the GDP originated from manufacturing, INFRA represents
the percentage of the GDP originated from transport service
and HEXPC represents the health expenditure per capita,
PHMR represents the sales of pharmaceutical products on the
domestic market, HEMP represents the number of persons
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(headcount) working in health care and social work and
PHICOV represents the percentages of population covered by
PHI.
Following Gupta and Mitra (2004), we build a collective
measure of the health status (HS) by using three main
indicators, namely, life expectancy and crude birth and death
rates. Life expectancy is defined as the average number of years
a population of a certain age would be expected to live, given a
set of age-specific death rates in a given year. Crude death rate
indicates the number of deaths occurring during the year, per
1,000 population estimated at midyear, whilst crude birth rate
indicates the number of live births occurring during the year,
per 1,000 population estimated atmidyear.
These are better indicators of the overall health status of the
population, as they are more reflective of the demographic
changes taking place in the economy and are influenced by
changes in health policy, including investment in health and
health services.
To compute the health status (HS), we used the principal
component analysis (PCA) – a dimensionality-reduction
method used to reduce the number of variables of a data set,
whilst preserving as much information as possible. This method
allows reducing a large set of correlated variables into a smaller
set of uncorrelated variables (called principal components) that
are ordered so that the first few retain most of the variation
present in all of the original variables (Stock andWatson, 2002).
Using the PCA, we reduced the original set of three health
indicators (i.e. life expectancy and crude birth rate and crude
death rate) to a smaller set of composite factors. As the PCA
method explains the variations of the selected variables better
than any other linear combination (Ang andMcKibbin, 2007),
by using it we avoidmulticollinearity problems.
Following Naik (2017), to build theHSwe estimated the total
variance clarified by the principal components for each country
(we applied the PCA model for 29 countries). Following Gray
(2017), we selected the value of the eigenvalue where it was
calculated to be more than one and each principal component
explained more than 70%; we removed the other components
with a value of less than one. By using the rotation method
Varimax, we rotated the components with the objective of
making them as simple as possible to interpret, establishing the
preliminary eigenvalues linked with the appropriate components,
then computed theHS.
Furthermore, we performed Parallel Analysis to ensure that the
appropriate number of components are selected.We ran “fapara”
in Stata to use the Parallel Analysis, we choose the eigenvalues in
the PCA column greater than the average eigenvalues in the
parallel analysis column. The results of the parallel analysis
confirm the appropriate number of selected components.
We assumed that there is an effect between variables in the
selected countries, so we use the panel data analysis technique.
In this technique, there is either a fixed effect or a random effect
between the independent variables and the dependent variable.
The fixed-effects model produces a constant estimate, but in
contrast, the Hausman test determines an appropriate model.
Panel data makes it possible to analyse the series of times and
different countries. Therefore, estimating panel data increases
estimation efficiency by analysing the data, increasing the
degree of freedom and reducing the collinearity between
variables. Another advantage of this technique is that it allows
for the analysis of data by using many variables at the same time
in a time series and selected countries (Petersen, 2004).
5. Results
We first used fixed-effect panel regression to find the
relationship between the industrial dynamics in health-care
context and the underlying economic growth in the selected
countries better. The indicators that we tried to identify are the
following: economic growth, FDI, health variables and
population variables. Table 3 represents the results of the fixed-
effect panel regression, which show that FDI has a direct and
significant relationship with economic growth. This means
that, by increasing FDI, economics provides more products to
more individuals and groups in society. The fixed-effect panel
regression specially the first column shows the positive impact
of the health expenditure on GDP, also the coefficients are
positive.
The results indicate a meaningful relationship between the
health industrial practices and economic growth in HS and a
clear positive relationship between the different aspects of the
economic development (such as the population) and economic
activity (such as production) with economic growth. These
results also confirm and expand the extant industrial marketing
literature (Anderson et al., 2019; Schiavone and Simoni, 2019;
Crick and Crick, 2020; Kang et al., 2020) by showing a nexus
between the industrial marketing dynamics of health-care
Table 2 Summary statistics
Variable obs. N Mean SD Minimum Maximum
GDPG 580 0.02527 0.313848 0.14814 0.11888
GDP 580 33,322.13 21,784.1 3,119.566 118,823.6
FDI 571 1,95e1 09 3.11e1 10 2.92e1 11 1,63e1 11
POPG 580 0.00533 0.008118 0.02258 0.026781
HS 551 3.17e-09 1.339395 3.28079 3.533659
URBAN 580 0.770545 0.115802 0.5075 0.9804
INDUS 574 0.144814 0.04871 0.0395 0.2824
INFRA 528 0.072066 0.06905 0.0014 0.3372
HEXP 518 2,777.347 1,945.03 153.62 9,241.27
PHMR 486 6,559.414 8,979.36 66.4 50,587.1
HEMP 499 819,300.3 1,112,595 17,624 5,942,000
PHICOV 457 0.3087593 0.2996092 0 0.958
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context and economic growth in the selected OECD countries.
The industrial practices in health-care context show the
collaborations amongst the actors along the value chain and
attest to show how, in the long run, the quality of health-care
delivery have led to an increase in economic growth and health
status of the population. This improvement is viewed as the
expansion of networks of users (e.g. patients, decision makers,
etc.) who are continuously involved.
Urbanisation and industrialisation are seen to influence
growth positively. Industrialisation is seen to have a negative
effect on health status (HS). The health variables show a
positive impact on economic growth; employment in the
health-care industry increases the economic growth and health
status, as well as the percentages of the population covered by
PHI. Also, in line of Muratoglu’s (2017) studies increasing
pharmaceutical sales boosts the economic growth.
Table 3 shows the results of the main panel regression,
specifically, the results of fixed effects and the consequences of
random effects. The second column shows the main HS as the
dependent variable. Also, the results of the random-effects model
indicate an increase in the health expenditure on health status
(HS). The results of the fixed effects are also similar. In empirical
analyses, the standard issue of choice between fixed and
random effect estimates (Petersen, 2004) is resolved by using
the Hausman test, the results of which (shown in the last row of
Table 3) suggest that a fixed effects estimator ismore appropriate.
The results of the second column show significant and
positive effects of health expenditure, pharmaceutical sales and
employment in health care on economic growth. The results
confirm that health expenditure has a positive and significant
impact on HS. Concerning the existence of increasing health
expenditure, an increase in one aspect of the health system
increases the HS. For example, a 1% increase in health care
spending over an annual period can impact a 1% increase in
HS. Furthermore, a 1% increase in employment in health care
can produce a 5.4% increase in HS. These results confirm the
results of previous studies that have shown a significant
relationship between these variables. The results in Table 3 –
column one – also show that population growth is significant.
The total population growth ratio has a coefficient equal to
0.762. A 1% increase in the ratio can thus, lead to a 76%
percent increase in growth rate. The urban variable is high the
same as the population ratio coefficient, which is 0.114; results
prove once more the urbanisation leads to the economic growth
in the selected countries. Contrariwise, the results of the second
column show that population growth has a negative impact on
health status. The industry and infrastructure variables support
this conclusion, increasing the industrial activities and transport
activities will harm for health status in the selected countries.
Finally, increasing the expenditure on health, employment in
health care and increasing the pharmaceutical market will lead to
economic growth and better health status. According to Gupta
and Mitra (2004), health expenditure is one of the important
factors for economic growth and health status.
Finally, we run the robustness check to control coefficient
estimates’ behaviour for country effects (Table 4). Following
Lu and White (2014), we use the “Checkrob” command on
Stata. Our findings show that the coefficients of independent
variables do not change much and their impacts on GDP
remain the same. However, FDI and the population covered by
PHI (PHICOV) have a robust positive impact on health status
(HS). On the other hand, industrialisation (INDUST) has a
robust and negative impact on health status (HS). However,
other coefficients do not changemuch of their impact onHS.
6. Discussion
These results try to explore the existing literature through
deepening of the studies that regard the industrial dynamics
within health-care context and their impact on economic
growth (Wright and Taylor, 2005; Anderson et al., 2019;
Yildirim and Calıskan, 2020; Crick and Crick, 2020).
Table 3 Results of statistical analysis
Variable Fixed-effect Fixed-effect Random-effect Random-effect
(Dependent variable) GDPG HS GDPG HS
GDP 0.09 (0.03) 0.06 (0.03)
FDI 0.0003 (0.04) 0.065 (0.03) 0.0002 (0.003) 0.062 (0.01)
POPG 0.762 (0.28) 0.131 (0.35) 0.719 (0.24) 0.24 (0.46)
HS 0.019 (0.08) 0.003 (0.02)
URBAN 0.114 (0.08) 0.66 (0.06) 0.04 (0.02) 2.97 (0.78)
INDUST 0.525 (0.09) 0.39 (0.34) 0.37 (0.05) 0.28 (0.31)
INFRA 0.031 (0.02) 0.63 (0.28) 0.024 (0.01) 0.32 (0.29)
HEXP 0.02 (0.02) 0.01 (0.01) 0.02 (0.01) 0.01 (0.01)
PHMR 0.03 (0.01) 0.01 (0.01) 0.03 (0.01) 0.01 (0.01)
HEMP 0.071 (0.01) 0.054 (0.01) 0.02 (0.01) 0.011 (0.01)
PHICOV 0.052 (0.01) 0.81
0.28
0.018 (0.01) 0.80 (0.24)
CONS 0.121 (0.02) 0.095 (0.03) 0.018 (0.01) 0.059 (0.02)
Number of groups 29 29 29 29
Number of observations 329 329 329 329
p-value 0.000 0.00 0.00 0.00
Hausman test 0.00 0.00
Notes: p-value< 0.1; p-value< 0.05
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We attempt to generate some empirical foundations. The
research introduces the main issues within the industrial
marketing literature and after focusses on the recent studies to
explore industrial practice that organise the relationships in a
context such as health care. Our research attested that
industrial performance in health-care context is tied to the
reliability and efficiency of processes; indeed, they are realised
by a series of phases, starting from the analytic phase, up to the
processing of pathology and the hospitalisation. These activities
are faced by different actors (e.g. physicians, physiotherapists
and nurses) and not all the stepsmay be clinical; in this vein, the
fragmentation and heterogeneity of the health-care delivery
process lead to a multidisciplinary industrial approach. For
those aspects, industrial dynamics might be improved, not only
by focussing on each delivery phase but also by enhancing the
level of coordination along the health-care value chain.
Thus, the present study offers a knowledge contribution to
the industrial marketing studies about the impact of industrial
dynamics on economic growth and health status that could
speed up and facilitate the innovation care process of the
health-care industry and the time to market for drugs and
medical devices in this context. The adoption of an emergent
innovation ecosystem in favour of a coordinated network of
industrial collaboration amongst different hospitals, physicians
and workers emerge as a crucial issue to improve different
dynamics for economic growth and health status in our selected
OECD countries. Therefore, the network management should
deal with a difficult trade-off between the increasing integration
of actors and the increased complexity of business process
analysis. Besides, the degree of complexity is related to an
abundance of factors, such as new required expertise, the
running costs of innovative infrastructure for the health-care
industry and hardware and softwaremaintenance.
7. Conclusions and implications
Our exploratory study offers theoretical implications for the
emerging stream of literature about the industrial dynamics in
health-care context (Anderson et al., 2019; Schiavone and
Simoni, 2019; Crick and Crick, 2020) and their impact on
economic growth and health status (Buttigieg et al., 2016; Bloom
et al., 2019; Yildirim and Calıskan, 2020) by exploring particular
form of industrial marketing approaches (e.g. market access) and
by using data on growth (GDP), FDI, population growth, urban
population, health status (HS), expenditures on health, industrial
and infrastructure, in 29 selectedOECDcountries.
Health-care organisations are rethinking their industrial
approaches to search for a competitive advantage in this
complex context. We also show managerial implications for
health-care practitioners about the fundamental relationship
amongst different actors (e.g. pharmaceutical companies,
payers, decision makers and key account managers). The aim is
to adopt business-to-business marketing strategies capable of
ensuring a lasting presence on themarket and an adequate level
of economic growth for population. This industrial strategy
should be a fundamental piece of all the functional divisions of
the pharmaceutical companies that should invest within
the entire supply chain management. Our research may be the
starting point to plan new industrial strategies to investigate the
necessity to create shared practices between the various
stakeholders involved in industrial markets to increase the time
to market for drugs and medical devices and an adequate level
of sustainability of the entire health-care supply chain.
Drawing on the above-reported results, some implications
for future research can be developed. The improvement of
industrial dynamics in health-care context could represent a
way to implement efficient co-working collaborations to
Table 4 Results of robustness check by country on the selected model
Variable Fixed-effect
Robustness check
by country Sign prediction Fixed-effect
Robustness check
by country Sing prediction
(Dependent
variable) GDPG GDPG HS HS
GDP 0.09 (0.03) 0.11 (0.07) 1
FDI 0.0003 (0.04) 0.0004 (0.04) 1 0.065 (0.03) 0.081 (0.05) 1
POPG 0.762 (0.28) 0.764 (0.31) 1 0.131 (0.35) 0.097 (0.14) –
HS 0.019 (0.08) 0.02 (0.09) 1
URBAN 0.114 (0.08) 0.108 (0.10) – 0.66 (0.06) 0.82 (0.24) 1
INDUST 0.525 (0.09) 0.519 (0.12) – 0.39 (0.34) 0.48 (0.41) –
INFRA 0.031 (0.02) 0.034 (0.03) 1 0.63 (0.28) 0.67 (0.49) 1
HEXP 0.02 (0.02) 0.03 (0.03) 1 0.01 (0.01) 0.07 (0.05) 1
PHMR 0.03 (0.01) 0.02 (0.01) – 0.01 (0.01) 0.04 (0.03) 1
HEMP 0.071 (0.01) 0.087 (0.03) 1 0.054 (0.01) 0.056 (0.02) 1




Number of groups 29 29 29 29
Number of
observations
329 329 329 329
p value 0.000 0.00 0.00 0.00
Hausman test 0.00 0.00
Notes: p value< 0.1; p value< 0.05
Industrial dynamics and economic growth
Song Ying et al.
Journal of Business & Industrial Marketing
advance competitive advantages and economic growth for
different countries. A newsworthy implication for scholars of
industrial marketing is that health-care industry gathers a rather
unique scale of adjoining business area (e.g. pharmaceutics and
e-health) whose main and different stakeholders could constantly
participate through long-term industrial relationships. Indeed, we
illustrated the positive association between the effectiveness and
efficiency of the health-care industry and the overall health status
of the population, which reduced bureaucratical health-care
processes and propose flexible collaboration amongst the health-
care value chain.
A reflection on the evolution of the collaborative business-to-
business marketing strategies in health care is also interesting.
This reflection is related to the practice-oriented implications
for industrial marketers and it is based on two points. Firstly,
this type of collaboration and relationships amongst different
actors (buyer/supplier and decision makers) has considerable
influence in public health-care decisions to speed up the time to
market and economic growth and to assure effectiveness and
efficiency of the industrial processes. Secondly, it is tangible
that the positive effect of industrial health practices more
patient-oriented improves the overall health status of the
population. These are evidence of the close correlation between
the industrial marketing performance and the economic growth
to sustain the health level of society and its economic
development (Wright and Taylor, 2005; Anderson et al., 2019;
Yildirim andCalıskan, 2020; Crick andCrick, 2020).
Finally, policymakers across the globe have started to look at
HIT as a key tool for making health-care industrial
performance more affordable, safer and more accessible. In
recent years, health status has boosted global economic growth,
but health-related variables need more advancement, as noted
in this study. The costs of a poor health care system can
increase costs in society. In such a turbulent global scenario,
reconsidering the role played by the health system in society is
essential to ensure the economic recovery of the countries.
Moreover, a poor health system not only damages the people
concerned but also represent a cost to society, reducing its
economic growth. Studies, including ours, have shown that the
higher health status increased the economic growth.
Using recent data from selected OECD countries over the
period 2000–2019, we investigate the dynamics of health-care
industrial markets and their impact on economic growth and
health status. We addressed the poor health status issue from
several different perspectives, including expenditure on health,
pharmaceutical market, employment in health-care sector and
industrial activities. In line with the literature, our results
confirm the positive effect of expenditure on health on
economic growth. Moreover, more performing sales channels
in the commercial sector of the pharmaceutical market, as well
as an increase in the health-care workforce and in PHI coverage
lead to higher health status and economic growth. Therefore,
the study suggests policymakers to focus on these different
industrial aspects of the health-care system. Health status can
be results of the expenditure on health on the long-term. The
empirical findings of this research emphasise the urgent need
for policymakers to implementing industrial changes in the
economic and social structure to increase the level of health
status. Addressing the problem of health-care delivery requires
actions aimed at ensuring increasing industrial investment on
the health system to improve the economic growth, the well-
being and the patients’ quality of life.
Note
1 Selected OECD countries: Australia, Austria, Belgium,
Canada, Chile, Czech Republic, Denmark, Estonia,
Finland, Germany, Greece, Hungary, Iceland, Israel,
Italy, Republic of Korea, Latvia, Lithuania, Luxemburg,
The Netherlands, New Zealand, Norway, Portugal, Slovak
Republic, Slovenia, Spain, Sweden, Turkey and the UK.
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